Sadiq Azam | Clinical Microbiology | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Sadiq Azam | Clinical Microbiology | Best Researcher Award

Associate Professor at University of Peshawsar, Pakistan

Dr. Sadiq Azam is an accomplished Associate Professor at the University of Peshawar, specializing in microbiology and biotechnology. With over a decade of academic and research experience, he has significantly contributed to understanding antibiotic resistance in pathogenic bacteria and the antimicrobial properties of medicinal plants. Dr. Azam began his academic career at Bacha Khan University and soon joined the University of Peshawar, where he has progressed through various academic ranks. His research includes several completed projects funded by the Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST), focusing on bacteriological profiling, phytochemical analysis, and molecular characterization of drug-resistant pathogens. A certified supervisor, he has mentored numerous M.Phil, PhD, and undergraduate students. He is an active member of academic boards across various institutions and plays a vital role in curriculum development, examination coordination, and teaching innovation. Dr. Azam is fluent in English, Urdu, and Pashto.

Professional Profiles

Scopus

Education 

Dr. Sadiq Azam earned his PhD in Biotechnology from the University of Peshawar, where he had also completed his Bachelor’s in Biotechnology. Prior to his university education, he studied pre-medical sciences at Nisar Shaheed Degree College, Resalpur. His academic journey began with a foundation in science at Government High School, Swabi. Throughout his education, he focused on understanding biological systems and laboratory methodologies, which laid the groundwork for his later research in antimicrobial resistance, pathogenic microorganisms, and medicinal plant compounds. His doctoral work, supported by a prestigious HEC Indigenous Scholarship, marked the beginning of a research career centered on the intersection of microbiology, molecular biology, and pharmacognosy. The academic rigor and scientific training received throughout his education have shaped his multifaceted expertise in clinical microbiology and applied biotechnology. His educational foundation continues to support his teaching, research supervision, and grant-funded investigations in Pakistan’s higher education and health sectors.

Experience 

Dr. Azam’s professional journey began in 2011 as Assistant Professor at Bacha Khan University, Charsadda. He joined the University of Peshawar, where he advanced from Lecturer to Assistant Professor and now serves as an Associate Professor in the Centre for Biotechnology and Microbiology. With over 13 years of teaching and research experience, he has been involved in undergraduate and postgraduate education, thesis supervision, and lab-based training. Beyond teaching, he has led and collaborated on national research projects focused on phytochemical screening and antibiotic resistance. Dr. Azam has played active administrative roles, including BS program coordination and examination management. He is also a member of several Boards of Studies across universities in Khyber Pakhtunkhwa, contributing to academic planning and quality assurance. His career highlights a balance of academic instruction, impactful research, institutional service, and mentorship in the fields of microbiology, biotechnology, and infectious disease research.

Awards and Honors 

Dr. Sadiq Azam was awarded the prestigious HEC Indigenous Scholarship for his M.Phil to PhD studies, recognizing his academic excellence and potential in scientific research. This scholarship provided vital support for his doctoral work in biotechnology at the University of Peshawar and laid the foundation for a research career focused on combating antimicrobial resistance and exploring plant-based therapeutic alternatives. In addition to academic funding, Dr. Azam has successfully secured competitive research grants from Pakistan’s Higher Education Commission (HEC) and the Directorate of Science and Technology (DoST). These projects, as both Principal and Co-Principal Investigator, reflect national recognition of his expertise and contributions. His continued involvement in funded research projects underscores his credibility and leadership in the scientific community. His honors not only represent personal achievements but also contribute to the growth of biotechnology research capacity in Pakistan. He remains committed to advancing microbiological science through innovation and collaboration.

Research Focus 

Dr. Sadiq Azam’s research centers on bacteriological profiling, molecular genetics of antibiotic resistance, and the pharmacological evaluation of medicinal plants. His primary focus is the identification of resistance genes in clinical isolates, including extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae. He employs molecular characterization techniques such as PCR, MIC testing, analytical profiling, and in-silico drug design to combat emerging bacterial threats. A parallel area of interest lies in the bioassay screening and phytochemical analysis of traditional medicinal plants like Silene conoidea, Sarcococca saligna, and Pinus wallichiana, aiming to discover novel antimicrobial compounds. His integrated approach bridges clinical microbiology with natural product chemistry, addressing global challenges in antibiotic resistance and infectious disease management. Through research supervision and project leadership, he actively contributes to building Pakistan’s research capacity in biotechnology, while aligning with global health priorities on antimicrobial stewardship and sustainable therapeutics.

Publication Top Notes

Title: Design and Validation of a Polyunit Epitope Vaccine Against Enterococcus faecium
Journal: Journal of Computational Biophysics and Chemistry
Summary:
This study likely focuses on the computational design and validation of a multi-epitope subunit vaccine targeting E. faecium, a notorious multidrug-resistant pathogen. The vaccine design may have used immunoinformatics tools to identify epitopes and predict immunogenicity.

Title: Towards Precision Epitopes Based Vaccine Against Enterococcus faecalis by Integrating Vaccinomics, Reverse Vaccinology and Biophysics Approaches
Journal: Biochemistry and Biophysics Reports
Summary:
The paper integrates vaccinomics and reverse vaccinology to identify precision epitopes for a vaccine targeting E. faecalis. It likely combines computational prediction, immunological profiling, and structural biophysics to develop a targeted vaccine strategy.

Title: Current Pattern of Antibiotic Resistance and Molecular Characterization of Virulence Genes in Klebsiella pneumoniae Obtained from Urinary Tract Infection (UTIs) Patients, Peshawar
Journal: PLOS ONE
Summary:
This research investigates antibiotic resistance patterns and the genetic basis of virulence in K. pneumoniae strains isolated from UTI patients in Peshawar. Likely includes PCR-based detection of virulence genes and antibiotic susceptibility profiling.

Title: Elucidating the Resistance Mechanisms and Binding Pattern of Novel Oxa-48-like Carbapenemases Covalent Inhibitors: A Hybrid Experimental and In Silico Approach
Journal: Journal of Molecular Structure
Summary:
The article explores how novel covalent inhibitors interact with Oxa-48-like carbapenemases—enzymes that confer resistance to carbapenem antibiotics. Uses both computational modeling and experimental data to understand resistance and inhibitor design.

Title: Green Synthesis and Characterisation of Desmodium podocarpum-Mediated Silver Nanoparticles and Their Biological Activities
Journal: Natural Product Research
Summary:
Focuses on the eco-friendly synthesis of silver nanoparticles using Desmodium podocarpum plant extract. Likely includes characterization (UV-Vis, SEM, FTIR) and evaluation of antimicrobial or antioxidant properties.

Conclusion 

Dr. Sadiq Azam stands as a leading academic and researcher in Pakistan’s biotechnology and microbiology landscape. His multidisciplinary expertise combines molecular microbiology, antimicrobial resistance research, and natural product pharmacology. With a strong academic foundation and over a decade of professional experience, he has contributed significantly to both science and education through impactful research, project leadership, and student mentorship. His work aligns with urgent global health issues such as drug-resistant infections and the search for alternative therapies. He has successfully led nationally funded projects and fostered collaborations across institutions. As an educator, Dr. Azam is deeply engaged in curriculum design, teaching innovation, and research supervision, shaping the next generation of scientists. His fluency in English, Urdu, and Pashto enables effective communication and outreach across diverse academic and community settings. Dr. Azam exemplifies the role of a dedicated researcher and educator committed to scientific advancement, public health improvement, and academic excellence in Pakistan.

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Published on by Global Diseases Research

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.

Yuling Zou | Diabetic Retinopathy | Best Researcher Award

Published on by Global Diseases Research

Dr. Yuling Zou | Diabetic Retinopathy | Best Researcher Award 

Nanchang University ,China

Dr. Yuling Zou is an accomplished medical doctor and Associate Chief Physician at the Affiliated Eye Hospital of Jiangxi Medical College, Nanchang University. With a focus on ophthalmology, she also serves as a master’s supervisor and holds influential roles across several ophthalmic research institutions in Jiangxi Province. A PhD graduate from the Ophthalmology Center at Sun Yat-sen University, Dr. Zou has made notable contributions to the understanding and treatment of retinal diseases. She has led several research initiatives supported by national and provincial funding, published extensively in SCI-indexed journals, and developed multiple patented ophthalmic devices. Her expertise spans diabetic retinopathy, age-related macular degeneration, and ferroptosis mechanisms in retinal diseases. She actively mentors postgraduate students and contributes to academic development as an expert reviewer and editorial board member. Her leadership, innovation, and dedication to improving ocular healthcare have earned her recognition as a prominent figure in ophthalmology.

🔹 Professional Profile

🏆Strengths for the Award

Dr. Yuling Zou is a highly accomplished medical researcher in the field of ophthalmology, with a specialized focus on diabetic retinopathy and retinal disease mechanisms. Her strong academic foundation—built through a Ph.D. from the esteemed Sun Yat-sen University—and her extensive clinical and research experience have positioned her as a leader in translational vision science. As Associate Chief Physician and Master’s Supervisor at Nanchang University, she has led multiple nationally and provincially funded research projects and published over ten SCI-indexed articles. Notably, her work on ferroptosis and berberine-based therapies has opened promising avenues in treating retinal vascular disorders. Her six patents in ophthalmic surgical innovations further highlight her drive for practical clinical impact. Dr. Zou’s commitment to mentoring young researchers, active participation in editorial boards, and rigorous peer review contributions exemplify her holistic contribution to academic and scientific progress. These attributes make her a deserving nominee for the Best Researcher Award.

🎓 Education

Dr. Yuling Zou completed her doctoral studies at the prestigious Ophthalmology Center of Sun Yat-sen University, specializing in retinal disorders and ocular pathology. Her academic training provided a strong foundation in both clinical ophthalmology and advanced biomedical research. She gained further expertise in translational medicine and molecular mechanisms through hands-on research in diabetic retinopathy and retinal ferroptosis. Her education emphasized an integrated approach to clinical problem-solving, encouraging her to pursue innovation through rigorous academic inquiry. In addition to her PhD, she has undergone continuous professional development through conferences, specialized training, and academic collaborations. Dr. Zou’s academic journey reflects a commitment to excellence and a deep-rooted interest in improving patient care through evidence-based research. Her interdisciplinary background has allowed her to bridge the gap between laboratory findings and clinical applications, paving the way for novel treatments in ocular diseases. She continues to inspire future clinicians and researchers as an academic mentor and educator.

💼 Experience

With years of clinical and research experience, Dr. Yuling Zou currently serves as Associate Chief Physician at the Affiliated Eye Hospital of Jiangxi Medical College, Nanchang University. She supervises postgraduate students and is actively involved in both clinical ophthalmology and basic research. Dr. Zou has led and completed multiple high-impact research projects, including one funded by the National Natural Science Foundation of China and five provincially supported grants. She has authored over 10 SCI-indexed articles and holds six patents for ophthalmic surgical tools and innovations. Her work spans diabetic retinopathy, retinal neovascularization, and ferroptosis mechanisms. As an active member of professional bodies and a reviewer for national grants and international journals, she plays a key role in academic and clinical peer review. Her combined clinical acumen, research productivity, and leadership in ophthalmology position her as a valuable contributor to the advancement of vision science and patient care in China.

🔬 Research Focus on Diabetic Retinopathy

Dr. Yuling Zou’s research is centered on retinal diseases, particularly diabetic retinopathy and age-related macular degeneration. Her primary scientific focus lies in understanding ferroptosis mechanisms in retinal vascular endothelial cells and how these contribute to vision-threatening conditions. She has explored the pharmacological effects of berberine as a therapeutic agent to inhibit oxidative stress and cell death in diabetic retinal complications. Her translational research bridges basic molecular insights with clinical ophthalmic applications, aiming to discover novel targets for intervention. Dr. Zou has led multiple government-funded research projects, resulting in impactful findings published in leading journals such as Experimental Eye Research. Additionally, her work on ocular neovascularization has contributed to the development of more effective treatment strategies for degenerative eye diseases. Through her investigations, she continues to advance the field of ophthalmology by offering innovative solutions to complex retinal pathologies and mentoring emerging researchers to carry forward this important scientific work.

📚 Publications Top Notes

Intraocular fluid analysis-guided precision therapy in the treatment of acute retinal necrosis syndrome

Authors: [Not fully listed – typically includes multiple contributors. Based on your format, there are at least four authors, with ellipses indicating more.]

Journal: Scientific Reports, 2025
Citations: 63

Summary:
This study presents a novel approach using intraocular fluid analysis to guide precision therapy for acute retinal necrosis syndrome (ARN)—a rare but vision-threatening inflammatory condition. By tailoring treatment based on the molecular and immunological characteristics found in ocular fluid samples, the research suggests improved outcomes in inflammation control, viral suppression, and vision preservation compared to conventional, generalized therapy.

📌 Conclusion

Dr. Yuling Zou exemplifies the qualities of a distinguished medical researcher and clinician through her unwavering commitment to advancing ophthalmic science and improving patient outcomes. Her academic rigor, clinical insight, and innovative approach to solving retinal health challenges have positioned her as a leader in the field. From pioneering berberine-based retinal therapies to developing patented surgical tools, Dr. Zou’s contributions have tangible impacts on both research and clinical practice. She has mentored the next generation of ophthalmologists while maintaining active roles in editorial and review committees, reinforcing her influence in the scientific community. Her accolades, leadership positions, and ongoing research reflect a career dedicated to excellence and service. Dr. Zou’s body of work not only enriches the field of ophthalmology but also embodies the spirit of progress and integrity that defines a deserving candidate for the Best Researcher Award. Her continued efforts promise further advancements in ocular healthcare and biomedical science.

 

Yonghao Gui | Pediatrics | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Yonghao Gui | Pediatrics | Best Researcher Award 

Professor at Children’s Hospital of Fudan University ,China

Dr. Yonghao Gui is a renowned Chinese pediatrician and academic leader in pediatric cardiology and child health. Born in Shanghai in 1958, he has devoted his career to advancing children’s healthcare through clinical practice, academic research, and institutional leadership. A graduate of Shanghai Medical University, Dr. Gui rose through clinical and academic ranks to become President of the Children’s Hospital at Fudan University and later Vice President and Executive Vice President of Fudan University. He has played a central role in developing China’s pediatric research infrastructure, with a special focus on congenital heart disease and neonatal health. As a leading figure in pediatrics, he has served as chairman of the Chinese Pediatric Association and chief editor of top pediatric journals. Widely published and respected, Dr. Gui has also represented China in global medical exchanges and training programs in the U.S., Japan, Germany, and Canada, contributing to international collaboration in pediatric care.

🔹Professional Profile 

🏆Strengths for the Award

Prof. Dr. Yonghao Gui is a pioneering figure in pediatric medicine with over four decades of impactful clinical, academic, and research contributions. As a global authority in pediatric cardiology, he has advanced the understanding of congenital heart disease through groundbreaking work on genetic and epigenetic regulation, maternal-fetal health, and miRNA pathways. His translational research, including antioxidant therapies and early-life interventions, bridges basic science with clinical care, positioning him at the forefront of precision pediatrics. Beyond research, Dr. Gui has demonstrated transformative leadership as President of the Children’s Hospital at Fudan University and Vice President of Fudan University, where he significantly enhanced pediatric research infrastructure in China. He has also influenced national child health policy, chaired key pediatric associations, and mentored generations of researchers. His prolific publications, editorial leadership, and international collaborations underscore his commitment to excellence, global knowledge exchange, and improving pediatric outcomes for children worldwide.

🎓 Education

Dr. Yonghao Gui began his medical education at Shanghai Medical University, where he earned his Bachelor of Science in Medicine from 1978 to 1982. During his early professional years, he pursued further academic enrichment in molecular biology through a continuing education program at the same institution. From 1991 to 1995, he was a visiting clinical research fellow at the Children’s Hospital of Philadelphia under the China/CHOP Academic Exchange Program, enhancing his expertise in pediatric cardiology. Later, from 1997 to 1999, he pursued a Master of Science degree in clinical epidemiology through the International Clinical Epidemiology Network (INCLEN) at its Southeast Asia Training Center in Bangkok. His commitment to lifelong learning also includes advanced hospital management courses at the University of British Columbia, Japan’s Osaka City University, and Germany’s Berlin Heart Institute. This rich educational background laid the foundation for his leadership in pediatric research and healthcare management in China.

💼Professional Experience 

Dr. Gui’s career spans over four decades of clinical, academic, and administrative excellence. He began as a resident at the Children’s Hospital of Shanghai Medical University and advanced to attending physician in pediatric cardiology. His international fellowship at the Children’s Hospital of Philadelphia enriched his clinical expertise. Upon return, he held leadership roles including Deputy Chief of Pediatrics and Cardiovascular Center. Rising steadily, he became Vice President, then President of the Children’s Hospital at Fudan University, and later served as Vice President and Executive Vice President of Fudan University. Dr. Gui directed the Research Institute at the Children’s Hospital and led national pediatric journals as editor-in-chief. He also chaired national pediatric associations and played a pivotal role in establishing the Neonatal Clinical Research Lab under the Ministry of Health. His professional trajectory reflects his dedication to child health, innovation in medical research, and excellence in institutional leadership within China’s top medical education systems.

🔬 Research Focus on Pediatrics

Dr. Yonghao Gui’s research primarily focuses on pediatric cardiology, especially the molecular and genetic underpinnings of congenital heart disease (CHD). As principal investigator on numerous national and municipal projects, he has explored early prevention, genetic regulation, microRNA roles, and epigenetic mechanisms in cardiac development. His work also delves into maternal-fetal interactions affecting neonatal cardiac health, including the impact of maternal diet, obesity, and metabolic disorders. Notably, his studies on gene-environment interactions and miRNA-mediated pathways offer insights into CHD pathogenesis. Dr. Gui has led multi-year projects funded by the National Natural Science Foundation and China’s “Double First-Class” initiative, focusing on early childhood health maintenance, cardiac enhancers, and transcription factor regulation. His translational research often utilizes zebrafish models and single-cell analysis to bridge clinical pediatrics and molecular science. Through these efforts, Dr. Gui is advancing precision medicine approaches for early detection, prevention, and intervention in pediatric cardiovascular diseases.

📚 Publications Top Notes

Antioxidant Management to Protect Male Offspring from the Progression of MASLD Programmed by Maternal Obesity in Mice

Authors: Jialing Zhang, Jiayu Wang, Da Xu, Fang Wu, Yonghao Gui
Journal: The Journal of Nutritional Biochemistry
Summary:
This study explores how antioxidant supplementation during pregnancy can mitigate the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) in male offspring of obese mice. The findings suggest that antioxidant treatment may reduce oxidative stress and hepatic lipid accumulation, thereby protecting the liver health of offspring affected by maternal obesity.

Promoting Glutathione Synthesis: A Possibility for Treating Cardiomyopathy Induced by a Maternal Western Diet

Authors: Jialing Zhang, Jiayu Wang, Da Xu, Yiting Gui, Fan Bai, Yu Huo, Li Cao, Yonghao Gui
Journal: Nutrients
Summary:
The study investigates the therapeutic potential of enhancing glutathione synthesis to treat cardiomyopathy in offspring exposed to a maternal Western diet. Results indicate that boosting antioxidant defense through glutathione pathways can improve heart structure and function in these mice, suggesting a preventative strategy for diet-induced cardiovascular programming.

Protective Effect of Antioxidants on Cardiac Function in Adult Offspring Exposed to Prenatal Overnutrition

Authors: Jialing Zhang, Li Cao, Wenji Wang, Yu Huo, Yuanzheng Zheng, Fang Wu, Yonghao Gui
Journal: Journal of Developmental Origins of Health and Disease
Summary:
This article reports on how prenatal antioxidant therapy helps preserve cardiac function in adult mice born to mothers with high-calorie diets. The study emphasizes that early nutritional interventions can buffer the long-term adverse effects of maternal overnutrition on cardiovascular health in offspring.

📌 Conclusion

Dr. Yonghao Gui stands as a pillar in pediatric medicine, seamlessly integrating clinical excellence, academic leadership, and groundbreaking research. With decades of contributions to pediatric cardiology, he has significantly advanced our understanding of congenital heart disease and its early prevention. His leadership roles at Fudan University and national pediatric associations underscore his commitment to enhancing healthcare infrastructure and medical education in China. Through cross-disciplinary and international collaborations, Dr. Gui has nurtured innovation in child health research and policy. His editorial work and textbook authorship reflect a deep dedication to shaping the next generation of pediatric professionals. Whether pioneering molecular studies or directing top-tier hospitals and academic units, Dr. Gui embodies the ideals of a clinician-scientist committed to societal well-being. His sustained impact across research, teaching, and leadership continues to inspire medical professionals and improve child health outcomes nationally and globally. He remains a respected voice in both China’s and the world’s pediatric communities.

Amer Khan | Education and Adherence | Best Scholar Award

Published on by Global Diseases Research

Dr. Amer Khan | Education and Adherence | Best Scholar Award 

Senior Lecturer at Universiti Sains Malaysia ,Malaysia

Dr. Amer Hayat Khan is a dedicated academic and researcher in the field of Clinical Pharmacy. Serving as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), he brings over a decade of expertise in teaching, clinical practice, and pharmaceutical research. A native of Pakistan, Dr. Khan has established himself as a prominent figure in pharmacyhttps://globaldiseases.org/amer-khan-education-and-adherence-best-scholar-award-1607/ education and research across Asia. He is actively involved in supervising postgraduate research, conducting clinical trials, and contributing to numerous international collaborations. His strong academic background, paired with a commitment to public health and community service, reflects his holistic approach to healthcare advancement. With over 300 publications, a Scopus H-index of 26, and a significant cumulative impact factor, Dr. Khan continues to influence both policy and practice in pharmacy. He maintains a strong presence in global research platforms, further extending his reach and collaborative potential across the scientific community.

🔹 Professional Profile

🏆Strengths for the Award

1. Academic Excellence and Educational Leadership
Dr. Khan holds a Ph.D. in Clinical Pharmacy and has demonstrated exceptional academic performance throughout his career. He has contributed significantly to curriculum development, undergraduate and postgraduate teaching, and the design of experiential learning programs such as clerkships and OSPhE assessments. His pedagogical methods integrate real-world clinical insights, reinforcing evidence-based learning.

2. Pioneering Research on Adherence and Education
Dr. Khan’s research, particularly in medication adherence, infectious diseases, and clinical education models, addresses crucial healthcare challenges. His recent work on TB treatment adherence using the Health Belief Model exemplifies innovative, theory-driven educational interventions with clinical impact.

3. Mentorship and Capacity Building
With supervision of over 50 postgraduate theses, including 29 Ph.D. candidates, Dr. Khan has made major contributions to building future research leaders. His mentorship spans multiple continents, fostering global capacity in pharmacy research.

4. Global Research Collaborations
Dr. Khan’s collaborations with institutions in South Asia, the Middle East, and Australia highlight his international influence. His work aligns with cross-border healthcare priorities such as antimicrobial resistance and geriatric pharmacotherapy, making him a central figure in translational research.

5. Outstanding Publication Record
With 300+ publications, a Scopus h-index of 26, and cumulative impact factor exceeding 426, his output reflects both quality and consistency. His articles are widely cited, spanning high-impact journals and addressing both regional and global public health needs.

6. Community and Public Health Engagement
Dr. Khan’s involvement in awareness campaigns, patient education initiatives, and antibiotic stewardship programs underlines his commitment to public service. His work bridges academic insight with real-world implementation, a rare and valuable quality in modern scholarship.

🎓 Education

Dr. Amer Hayat Khan pursued his higher education with a clear focus on pharmacy. He obtained his Ph.D. in Clinical Pharmacy from Universiti Sains Malaysia (USM), where he later joined the academic faculty. Prior to that, he completed his M.Phil and Bachelor of Pharmacy degrees at Gomal University in Pakistan. His academic training laid a strong foundation in both pharmaceutical sciences and clinical pharmacy practice, equipping him with in-depth knowledge essential for advanced teaching and research. To complement his formal education, Dr. Khan earned certifications in Good Clinical Practices (GCP) from the Ministry of Health, Malaysia. These qualifications have allowed him to operate effectively in both academic and clinical environments, emphasizing evidence-based approaches in pharmacy education and research. His diverse educational background supports his multifaceted roles as a teacher, researcher, and mentor in the field of clinical pharmacy at the international level.

💼 Experience

Dr. Amer Hayat Khan has over a decade of academic and clinical experience in pharmacy. Since October 2011, he has served as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM). His responsibilities include teaching undergraduate and postgraduate pharmacy courses, supervising thesis research, and conducting structured hospital visits for pharmacy clerkship. Dr. Khan also plays a pivotal role in training students through Objective Structured Pharmacy Examinations (OSPhE), problem-solving sessions, and community health initiatives. As a Clinical Pharmacy Specialist, he integrates research with teaching and service delivery, enhancing pharmaceutical care training. He has also supervised over 50 postgraduate research projects, contributing extensively to capacity-building in pharmacy education. His experience spans across national borders, involving active collaborations with research institutions in the Middle East, South Asia, and Australia. His career reflects a commitment to advancing pharmacy practice through education, innovation, and international research partnerships.

🏆Awards and Honors

Dr. Amer Hayat Khan has been the recipient of numerous awards and competitive research grants throughout his academic career. These accolades recognize his outstanding contributions to clinical pharmacy education, research, and service. He is actively engaged in academic peer-review processes, serving as a reviewer for prestigious journals and as an examiner for postgraduate theses at various universities. His extensive research portfolio, supported by international and institutional grants, has earned him recognition within and beyond Malaysia. He has played a key role in advancing pharmaceutical sciences, particularly through impactful studies on infectious diseases, antibiotic stewardship, and adherence issues. With a cumulative article impact factor of over 426.50 and an abstract impact factor exceeding 144.44, his scientific output has made a significant contribution to global pharmacy research. His achievements are not only academic but also reflect his dedication to public health and community engagement, solidifying his position as a leader in the field.

🔬 Research Focus on Education and Adherence

Dr. Amer Hayat Khan’s research interests center around Clinical Pharmacy with a strong focus on Infectious Diseases, Antibiotic Stewardship, Geriatric Issues, Adherence Challenges, and Epidemiology. His work aims to bridge the gap between clinical practice and academic research by addressing real-world pharmaceutical challenges. He has supervised 29 Ph.D. and numerous master’s research projects, often involving clinical trials, observational studies, and pharmacological interventions. His research frequently explores medication adherence in elderly populations and the optimization of antibiotic use to combat resistance. Through international collaborations with institutions across Saudi Arabia, India, Pakistan, UAE, and Australia, he has contributed to a global understanding of pharmacy practices. Dr. Khan’s publications are widely cited, and his projects often emphasize evidence-based practices that can inform healthcare policy and improve clinical outcomes. His research agenda reflects a commitment to improving patient care and enhancing pharmaceutical education through innovative, interdisciplinary approaches.

📚 Publications Top Notes

Pharmacist-led Education Intervention to Improve Pulmonary Tuberculosis Treatment Adherence Through the Health Belief Model in Malaysia: A Study Protocol for a Randomized Trial

Authors: R Ahmad, SMS Ghadzi, IABH Ali, SAS Sulaiman, AH Khan
Journal: Monaldi Archives for Chest Disease, 2025
Summary: This study outlines a randomized controlled trial (RCT) protocol investigating the effectiveness of a pharmacist-led intervention based on the Health Belief Model (HBM) to improve treatment adherence among pulmonary TB patients in Malaysia. The intervention aims to address patient beliefs, perceived severity, susceptibility, and barriers to adherence, using structured educational sessions.

Risk Factors of Acute Kidney Injury Patients Presenting to Tertiary Care Hospital

Authors: A Khan, W Khan, A Jabbar, M Khan, Z Ullah
Journal: Pakistan Journal of Intensive Care Medicine, Vol. 5(01), Page 92, 2025
Summary: This cross-sectional study identifies clinical and demographic risk factors associated with Acute Kidney Injury (AKI) among patients in a tertiary care setting in Pakistan. Major findings point to the role of comorbidities such as diabetes, hypertension, and sepsis as leading contributors.

Evaluation of Social and Clinical Factors Associated with Adverse Drug Reactions Among Children with Drug-Resistant Tuberculosis in Pakistan

Authors: MS Said, R Fatima, R Ahmad, MBA Al Rawi, F Jan, S Faisal, I Khan, AH Khan, et al.
Journal: Tropical Medicine and Infectious Disease, 10(7), Article 176, 2025
Summary: This research examines the correlation between social determinants (like caregiver education) and clinical features (polypharmacy, nutritional status) in the incidence of adverse drug reactions in pediatric DR-TB patients. It advocates for improved monitoring and targeted risk assessments.

Impact of COVID-19 on Clinical Characteristics in Type 2 Diabetes Patients: A Prospective, Longitudinal, Observational Study

Authors: T Azim, AH Khan, F Sadiq, SAS Sulaiman, DAM Noor, U Wahab, O Ishtiaq
Journal: Diabetes Research and Clinical Practice, Article 112316, 2025
Summary: This study explores how COVID-19 altered clinical outcomes and glycemic control in T2DM patients over time. Results reveal significant metabolic derangements, increased insulin requirements, and higher hospitalization rates during infection periods.

Systematic Review and Meta-analysis Protocol of Impact of Pharmacist-Led Antibiotic Stewardship Audit-Feedback Intervention

Authors: DS Jawhar, AH Khan, K Alam
Journal: MethodsX, Article 103399, 2025
Summary: The paper proposes a protocol for a systematic review and meta-analysis aimed at evaluating the effectiveness of pharmacist-led audit-feedback interventions on antibiotic prescribing practices. It adheres to PRISMA-P standards and seeks to inform global antimicrobial stewardship policies.

Prevalence of Cardiovascular Disease Among Tuberculosis Patients in Penang General Hospital, Malaysia

Authors: B Kingrani, AH Khan, SN Harun, FAS Khiery, IAH Ali, A Qureshi
Journal: [Details not specified], 2025
Summary: This epidemiological study assesses the coexistence of cardiovascular disease (CVD) among TB patients, highlighting a high prevalence and stressing the need for integrated CVD screening in TB care programs.

Cardiovascular Mortality Among Tuberculosis Patients

Authors: B Kingrani, AH Khan, SN Harun, A Qureshi, IAH Ali, MB Al-Rawi, I Khan
Journal: [Details not specified], 2025
Summary: The study reports an increased rate of cardiovascular-related deaths in TB patients, suggesting that TB-induced systemic inflammation might accelerate cardiovascular risks. Calls for enhanced cardiovascular monitoring are made.

Exploring Antibiotic Resistance Patterns in Escherichia coli Isolates from Urinary Tract Infections: A Retrospective Study

Authors: R Alkhawaldeh, L Gharaibeh, AH Khan, K Abu Hammour, M Zawiah, et al.
Journal: Journal of Clinical Medicine, 14(9), Article 3196, 2025
Summary: Retrospective data analysis reveals increasing antibiotic resistance in E. coli isolates, especially to fluoroquinolones and beta-lactams. The paper recommends urgent antimicrobial stewardship and rational prescription practices.

Parental Awareness and Practices of Self-Medication with Antibiotics Among Hospitalized Children: Findings and Implications from a Cross-Sectional Study

Authors: ZU Mustafa, AH Khan, M Salman, SN Harun, J Meyer, B Godman
Journal: Advances in Human Biology, 2025
Summary: This cross-sectional study identifies significant gaps in parental understanding of antibiotic use in pediatric patients. The study emphasizes the role of public health education in combating antibiotic misuse.

Baseline Predictors of Antibiotics De-escalation from Empirical Therapies in an Intensive Care Unit: A Five-Year Retrospective Study

Authors: AL Arulappen, AH Khan, M Danial, SS Hasan, TS Chow, NJ Ahmed, et al.
Journal: BMC Infectious Diseases, 25(1), Article 369, 2025
Summary: Over a 5-year period, the study identifies clinical predictors (e.g., culture sensitivity results, clinical stability) that influenced successful antibiotic de-escalation in ICU patients. The study supports promoting de-escalation to reduce resistance.

📌 Conclusion

Dr. Amer Hayat Khan exemplifies a balanced academic professional with strengths in teaching, research, and clinical practice. His extensive educational background, coupled with over a decade of academic service at Universiti Sains Malaysia, underlines his dedication to advancing the field of Clinical Pharmacy. As a mentor, he has significantly contributed to postgraduate education and research supervision, while his global research collaborations highlight his international impact. Dr. Khan’s work in infectious diseases, antibiotic stewardship, and elderly care aligns with current healthcare priorities, reflecting his forward-thinking approach. His recognition through awards, grants, and high-impact publications attests to the quality and relevance of his contributions. Committed to community health and evidence-based practice, he continues to influence the next generation of pharmacists and healthcare professionals. His career trajectory positions him not only as an academic leader but also as a valuable contributor to global public health and clinical pharmacy advancement.

Israël Maoneo | Neurosurgery | Best Researcher Award

Published on by Global Diseases Research

Dr. Israël Maoneo | Neurosurgery | Best Researcher Award 

Doctor at University of Kisangani ,Congo, Democratic Republic of the

Dr. Israël Maoneo Azabali, born in Bafwasende, Democratic Republic of Congo, is a seasoned medical doctor and academic with deep expertise in surgery and neurochirurgy. Currently a specialist in neurosurgery-in-training since 2021, he has built a robust clinical and academic career rooted in Kisangani. He began his medical journey with a Doctorate in Medicine from the University of Kisangani, later specializing in surgery. Beyond his medical practice, he serves as a senior lecturer and researcher in the Department of Surgery at the University of Kisangani. Known for his commitment to surgical excellence and scholarly contribution, he has authored numerous peer-reviewed publications focusing on spinal injuries, cranio-encephalic trauma, and rare neurosurgical cases. Dr. Maoneo is multilingual and active in continental and global neurosurgical forums. His reputation as both a clinician and academic is reinforced by decades of impactful service in resource-limited healthcare settings across the Congo.

🔹 Professional Profile

🏆Strengths for the Award

  1. NeurosurgeryHigh-Impact Research Focus: His work on neurotrauma, spinal injuries, and rare neurosurgical cases directly addresses urgent, under-researched healthcare challenges in resource-limited settings.

  2. Clinical Relevance: Research rooted in real-world clinical challenges with outcomes that influence both practice and policy—particularly in Sub-Saharan Africa.

  3. Publication in Peer-Reviewed Journals: Notably, his recent contribution in the Journal of Clinical Neuroscience shows international recognition and scientific rigor.

  4. Academic Leadership: Two decades of academic service, including as a Senior Lecturer, supervising young researchers, and organizing scientific programs.

  5. Resilience and Innovation: Develops and applies low-tech surgical strategies that offer solutions despite infrastructure constraints—key for global health equity.

  6. Global Collaboration: Participation in continental neurosurgical forums and collaborations with international teams underline his global engagement and research dissemination.

🎓 Education

Dr. Maoneo’s educational pathway reflects a strong foundation in philosophy, medicine, and surgical sciences. He began his academic journey at the Petit Séminaire Anoalite de Lingondo, where he earned his State Diploma in Latin and Philosophy. He then obtained a Philosophy degree from Philosophat Saint Augustin in Kisangani. His passion for medicine led him to the University of Kisangani, where he earned his Doctorate in Medicine, Surgery, and Obstetrics. He advanced further to obtain a Specialist Diploma in Surgery from the same university in 2019. Continuing his quest for excellence, he is currently pursuing specialization in Neurosurgery, a journey he began in 2021. His education has been enriched by several training courses and international congresses, including programs in neurotrauma, spinal surgery, and clinical biostatistics. Dr. Maoneo has also been trained in research methodology, medical writing, and health informatics, equipping him with interdisciplinary knowledge essential to both clinical and academic success.

💼 Experience

Dr. Maoneo’s professional career spans over two decades, blending clinical service and academic leadership. Since 2017, he has been serving as a Senior Lecturer in the Department of Surgery at the University of Kisangani, while also working as a treating physician at the university clinics. He previously held positions as Assistant Lecturer from 2010 to 2017. Before his academic ascent, he worked as Medical Director of Anoalite Hospital in Wamba (2007–2009), and later as Chief Medical Officer of the Bafwasende Health Zone (2009–2010). Throughout his clinical career, Dr. Maoneo has remained dedicated to patient care in resource-constrained settings, performing surgeries and managing complex trauma cases. His leadership roles in both urban hospitals and rural health systems underscore his adaptability and commitment. His experiences also include organizing and participating in medical seminars, scientific research, and mentoring young medical professionals, establishing him as a pillar in Congo’s surgical and academic communities.

🔬 Research Focus on Neurosurgery

Dr. Maoneo’s research primarily centers on neurotraumatology and spinal cord pathologies in low-resource settings. His studies address the clinical and radiological evaluation of traumatic and non-traumatic radiculomedullary compressions, thoraco-lumbar spine injuries, extradural tumors, and pediatric neurosurgical anomalies. He has explored surgical techniques suitable for environments with limited infrastructure, with a focus on optimizing outcomes despite technical constraints. His work on hydrocephalus, odontoid fractures, fibrolipomas, and Fournier gangrene exemplifies a broad yet coherent interest in critical care surgery and neurological emergencies. Collaborating with national and international neurosurgical teams, he contributes to comparative studies on surgical interventions, offering valuable data for improving patient outcomes in sub-Saharan Africa. Moreover, Dr. Maoneo frequently addresses post-operative complications, spinal fixation strategies, and the epidemiological burden of neurosurgical conditions. His research approach blends clinical insight with statistical rigor, aiming to influence policy, improve surgical standards, and enhance the training of future neurosurgeons in Central Africa.

📚 Publications Top Notes

📄 Challenges and Strategies in the Surgical Management of Traumatic Spinal Cord Injuries in the Democratic Republic of the Congo

Authors: Beltchika A, Maoneo I, Ketani T, Mukuetala P, Ojo O, Ntsambi G, et al.

Journal: Journal of Clinical Neuroscience (2024)

Summary:
Due to major challenges—such as delayed presentations, lack of pre-hospital care, equipment shortages (implants, imaging), and limited rehabilitation—the Kinshasa facility adapted by using improvised instrumentation and low-tech surgical strategies. Despite these adaptations, outcomes were comparable to standard care, demonstrating resilience and innovation in resource-limited contexts

📌 Conclusion

Dr. Israël Maoneo Azabali stands out as a highly committed physician, educator, and researcher who has significantly impacted surgical and neurosurgical practice in the Democratic Republic of Congo. His dedication to clinical care, particularly in resource-limited environments, underscores his resilience and adaptability. Over the years, he has seamlessly combined academic responsibilities with hands-on medical practice, mentoring students, publishing influential research, and contributing to regional and international scientific discourse. His focus on neurotrauma, spinal cord injuries, and surgical outcomes has helped build a deeper understanding of complex conditions in low-resource contexts. Fluent in multiple languages and trained across diverse medical environments, he effectively communicates and collaborates on both local and international stages. Dr. Maoneo’s commitment to ongoing specialization, research excellence, and medical education positions him as a pivotal figure in the evolution of neurosurgery in Central Africa. His legacy is one of knowledge-sharing, clinical compassion, and unwavering service to humanity.